Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Merck & Co., Inc. | 50,934 | reported | 10 May 2016 | tx 28+431,615−39,118 |
| Axcella Health Inc. | 40,000 | reported | 19 May 2022 | tx 1+40,000 |
| Rubius Therapeutics, Inc. | 25,000 | reported | 12 May 2022 | tx 5+125,000 |
| Azenta, Inc. | 13,042 | reported | 12 Feb 2024 | tx 9+17,633−4,591 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2024 | GRANT_AWARD | Azenta, Inc. | 2,465 | 65.93 USD | |
| 13 Feb 2023 | GRANT_AWARD | Azenta, Inc. | 3,604 | 0.00 USD | |
| 11 Feb 2022 | GRANT_AWARD | Azenta, Inc. | 1,922 | 0.00 USD | |
| 19 May 2022 | GRANT_AWARD | Axcella Health Inc. | 40,000 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 12 Nov 2021 | SALE | Azenta, Inc. | 2,831 | 114.13 USD | |
| 13 May 2021 | SALE | Azenta, Inc. | 1,760 | 90.00 USD | |
| 12 May 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 05 Feb 2021 | GRANT_AWARD | Azenta, Inc. | 1,760 | 0.00 USD | |
| 21 May 2020 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 11 Feb 2020 | GRANT_AWARD | Azenta, Inc. | 2,831 | 0.00 USD | |
| 23 May 2019 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 08 Feb 2019 | GRANT_AWARD | Azenta, Inc. | 4,033 | 0.00 USD | |
| 07 Sept 2018 | GRANT_AWARD | Azenta, Inc. | 1,018 | 0.00 USD | |
| 17 Jul 2018 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 10 May 2016 | GRANT_AWARD | Merck & Co., Inc. | 50,934 | 0.00 USD | deriv |
| 22 Feb 2016 | GRANT_AWARD | Merck & Co., Inc. | 7,738 | 50.77 USD | |
| 02 May 2015 | EXERCISE | Merck & Co., Inc. | 3,818 | 0.00 USD | |
| 02 May 2015 | TAX_WITHHOLDING | Merck & Co., Inc. | 1,980 | 59.86 USD | |
| 02 May 2015 | EXERCISE | Merck & Co., Inc. | 3,818 | 59.86 USD | deriv |
| 01 May 2015 | GRANT_AWARD | Merck & Co., Inc. | 46,440 | 0.00 USD | deriv |
| 23 Feb 2015 | GRANT_AWARD | Merck & Co., Inc. | 5,001 | 58.30 USD | |
| 09 May 2014 | GRANT_AWARD | Merck & Co., Inc. | 41,265 | 0.00 USD | deriv |
| 04 May 2014 | TAX_WITHHOLDING | Merck & Co., Inc. | 1,799 | 58.22 USD | |
| 04 May 2014 | EXERCISE | Merck & Co., Inc. | 4,103 | 0.00 USD |